:: Library Catalog

Cover Image

Saved in:

Bibliographic Details
Main Authors:	C. Ramos‐Belinchon, N. Plevris
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Alimentary Pharmacology & Therapeutics
Online Access:	https://onlinelibrary.wiley.com/doi/10.1111/apt.70113
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Editorial: Real‐World Evidence of Upadacitinib—An Effective Induction Therapy for Crohn's Disease? Authors' Reply
by: Nicolas Richard, et al.
Published: (2025)

Editorial: Upadacitinib—A Promising Induction Agent for Paediatric Crohn's Disease?
by: Vincenzo Stranges, et al.
Published: (2025)

Editorial: Upadacitinib in Perianal Crohn's Disease
by: Manjeet Kumar Goyal, et al.
Published: (2026)

One‐Year Effectiveness of Upadacitinib in Perianal Crohn's Disease: A Real‐World GETAID Study
by: Nicolas Richard, et al.
Published: (2026)

Upadacitinib for Induction of Remission in Paediatric Crohn's Disease: An International Multicentre Retrospective Study
by: Shlomi Cohen, et al.
Published: (2025)

Research Communication: Combination Therapy of Upadacitinib With Infliximab, Risankizumab, Ustekinumab or Vedolizumab for Refractory Crohn's Disease: A Descriptive Case Series
by: Rahul S. Dalal, et al.
Published: (2025)

Editorial: Mesenchymal Stem Cell Therapy for Perianal Fistulising Crohn's Disease—Effective or Hype?
by: Jeffrey D McCurdy, et al.
Published: (2024)

Network Meta‐Analysis: Comparative Efficacy of Biologics and Small Molecules in the Induction and Maintenance of Remission in Crohn's Disease
by: Mohammad Shehab, et al.
Published: (2025)

Editorial: Seton Use in Perianal Fistulising Crohn's Disease. Authors' Reply
by: Jeffrey D McCurdy, et al.
Published: (2025)

Evaluation of the Effectiveness and Safety of Mesenchymal Stem Cell Treatment in Fistulising Crohn's Disease: An International Real‐Life Retrospective Multicentre Cohort Study
by: Péter Bacsur, et al.
Published: (2024)

Editorial: Examining Perianal Fistulising Crohn's Disease Through the Lens of Wound Repair
by: Tim Eglinton
Published: (2025)

Editorial: Endoscopic Activity is an Essential Tool for Patients' Management, Even in Mild Crohn's Disease
by: Marco Mendolaro, et al.
Published: (2025)

Editorial: Beyond Resection—Rethinking Postoperative Management in Colonic Crohn's Disease. Authors' Reply
by: José Luis Rueda García, et al.
Published: (2026)

Letter: Real‐Life Evaluation of Effectiveness of Mesenchymal Stem Cell Treatment in Fistulising Crohn's Disease Emphasises the Importance of Appropriate Patient Selection and Centre Expertise
by: Weilun Gao, et al.
Published: (2024)

Editorial: Real‐World Effectiveness of Mirikizumab in Ulcerative Colitis—A Valuable but Preliminary Glimpse
by: Mark A. Ainsworth, et al.
Published: (2025)

Inflammatory Potential of the Diet and Risk of Crohn's Disease and Ulcerative Colitis
by: Antoine Meyer, et al.
Published: (2025)

Editorial: “Striding” Towards Transmural Healing: Redefining Deep Remission as a Treatment Target in Crohn's Disease
by: Rohita Reji, et al.
Published: (2026)

Letter: Real‐Life Evaluation of Effectiveness of Mesenchymal Stem Cell Treatment in Fistulising Crohn's Disease Emphasises Importance of Appropriate Patient Selection and Centre Expertise—Authors' Reply
by: Péter Bacsur, et al.
Published: (2024)

Letter: Bowel Preparation Quality in Patients With Crohn's Disease
by: Tamar Schildkraut, et al.
Published: (2024)

Letter: Crohn's Disease or Comorbidity? Reassessing Opioid Prescribing Patterns
by: Kuan‐Ju Lin, et al.
Published: (2025)

Editorial: Real‐World Effectiveness of Mirikizumab in Ulcerative Colitis—A Valuable but Preliminary Glimpse. Authors' Reply
by: Shinichiro Shinzaki, et al.
Published: (2025)

Editorial: Fistula Calprotectin as a Biomarker of Local Inflammation and Treatment Response in Perianal Fistulising Crohn's Disease. Authors' Reply
by: Runqi Wang, et al.
Published: (2026)

Letter: Inflammatory Potential of the Diet and Risk of Crohn's Disease and Ulcerative Colitis
by: Zhidong Zhou, et al.
Published: (2025)

Letter: Bowel Preparation Quality in Patients With Crohn's Disease—Authors' Reply
by: Virginia Solitano, et al.
Published: (2024)

Editorial: Development and Validation of a Multimodal Machine Learning Model for Diagnosing and Assessing Risk of Crohn's Disease in Patients With Perianal Fistula
by: Alyssa M. Parian, et al.
Published: (2025)

Editorial: The prevalence and outcomes of perianal Crohn's disease across treatment eras
by: Daniel Tassone, et al.
Published: (2024)

Letter: The Simple Endoscopic Score for Predicting Crohn's Disease Progression—Not as Simple as It Sounds
by: Ziheng Calvin Xu, et al.
Published: (2025)

Editorial: The Milan Score as Supportive Evidence of Gastro‐Oesophageal Reflux Disease. Authors' Reply
by: Stefano Siboni, et al.
Published: (2026)

Editorial: Development and Validation of a Multimodal Machine Learning Model for Diagnosing and Assessing Risk of Crohn's Disease in Patients With Perianal Fistulae: Authors' Reply
by: Lichao Qiao, et al.
Published: (2025)

Editorial: Infliximab induction therapy in pediatric Crohn's disease—A cost‐effective strategy?
by: Neil Chanchlani, et al.
Published: (2024)

Fistula Calprotectin as a Biomarker of Local Inflammation and Treatment Response in Perianal Fistulizing Crohn's Disease
by: Runqi Wang, et al.
Published: (2026)

Editorial: The Milan Score as Supportive Evidence of Gastro‐Oesophageal Reflux Disease
by: Javier Chahuán, et al.
Published: (2026)

Volatomics for Diagnosis and Risk Stratification of MASLD: A Proof‐Of‐Concept Study
by: R. Sinha, et al.
Published: (2025)

Letter: ‘Early Ileal Resection in Crohn's Disease Is Not Associated With Severe Long‐Term Outcomes: The ERIC Study’
by: Matthias Kelm, et al.
Published: (2025)

Letter: Re‐Examining Seton Efficacy in Perianal Crohn's Disease—Considerations for Outcome Measurement and Clinical Interpretation
by: Dingsheng Liu, et al.
Published: (2025)

Crohn's Disease With Latent Tuberculosis Infection or Intestinal Tuberculosis: Rapid Discrimination by Targeted Next‐Generation Sequencing
by: Lingna Ye, et al.
Published: (2025)

Editorial: Infliximab induction therapy in paediatric Crohn's disease — A cost‐effective strategy? Authors' reply
by: Stephanie A. Vuijk, et al.
Published: (2024)

Editorial: Foretelling the future—Emerging role of magnetic resonance enterography as a prognostic tool in Crohn's disease
by: Siri A. Urquhart, et al.
Published: (2024)

Twenty‐Year Trends in Colectomy Rates and Advanced Therapy Prescribing in Lothian, Scotland
by: Alexander T. Elford, et al.
Published: (2025)

Letter: Crohn's Disease With Latent Tuberculosis Infection or Intestinal Tuberculosis: Rapid Discrimination by Targeted Next‐Generation Sequencing
by: Maryam Irshad, et al.
Published: (2025)